NEW YORK (GenomeWeb News) – Seegene said today that Health Canada has approved two of its multiplex diagnostic tests for respiratory infections.
 
Health Canada awarded Medical Device Licenses for the company’s PCR-based Seeplex RV5 Auto Capillary Electrophoresis Screening and RV12 Auto Capillary Electrophoresis Detection tests.
 
The Seeplex RV5 test detects influenza A, influenza B, and respiratory syncytial virus A/B, and screens for 11 viruses; while the RV12 test identifies 12 viruses individually.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.